Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

2014 ACBS Landline-Cellphone Combined Prevalence Tables


TABLE 10. Estimated percent using inhaled short acting beta agonists among adults1 with current2 or active3 asthma status by state/territory – BRFSS Asthma Call-back Survey Land Line And Cell Phone Combined Sample, United States, 2014

State/Territory Current Active
Sample
size±
% SE§ 95% CI Sample
size
% SE 95% CI
Connecticut 210 51.2 6.0 (39.4 – 63.0) 225 52.0 5.9 (40.4 – 63.6)
District of Columbia 108 54.7 11.1 (32.9 – 76.5) 111 62.1 9.9 (42.7 – 81.5)
Georgia 132 35.8 6.7 (22.7 – 48.9) 138 36.8 6.7 (23.7 – 49.9)
Hawaii 185 49.4 6.3 (37.1 – 61.7) 195 47.0 6.0 (35.2 – 58.8)
Illinois 187 53.5 5.4 (42.9 – 64.1) 202 50.6 5.1 (40.6 – 60.6)
Indiana 488 58.9 3.3 (52.4 – 65.4) 509 55.4 3.4 (48.7 – 62.1)
Iowa 228 51.5 4.9 (41.9 – 61.1) 251 50.4 4.6 (41.4 – 59.4)
Maine 290 54.9 4.3 (46.5 – 63.3) 312 51.3 4.1 (43.3 – 59.3)
Maryland 209 53.9 6.1 (41.9 – 65.9) 218 52.8 5.8 (41.4 – 64.2)
Michigan 414 54.1 3.5 (47.2 – 61.0) 444 52.1 3.2 (45.8 – 58.4)
Mississippi 128 57.9 6.6 (45.0 – 70.8) 135 50.8 6.9 (37.3 – 64.3)
Missouri 255 62.2 4.8 (52.8 – 71.6) 260 63.2 4.7 (54.0 – 72.4)
Montana 253 50.5 5.2 (40.3 – 60.7) 264 47.4 5.1 (37.4 – 57.4)
Nebraska 681 46.8 3.4 (40.1 – 53.5) 718 43.2 3.4 (36.5 – 49.9)
Nevada 130 57.2 6.3 (44.9 – 69.5) 148 52.1 6.0 (40.3 – 63.9)
New Hampshire 219 51.2 4.7 (42.0 – 60.4) 228 48.7 5.0 (38.9 – 58.5)
New Jersey 420 42.6 3.9 (35.0 – 50.2) 448 41.5 3.7 (34.2 – 48.8)
New Mexico 230 53.8 5.3 (43.4 – 64.2) 258 49.4 4.8 (40.0 – 58.8)
New York 115 50.9 7.0 (37.2 – 64.6) 118 50.9 7.2 (36.8 – 65.0)
North Carolina 130 52.0 8.2 (35.9 – 68.1) 137 55.7 7.3 (41.4 – 70.0)
Ohio 337 48.3 4.2 (40.1 – 56.5) 359 45.6 4.0 (37.8 – 53.4)
Oklahoma 229 44.1 4.3 (35.7 – 52.5) 219 50.3 4.6 (41.3 – 59.3)
Oregon 165 42.0 6.7 (28.9 – 55.1) 191 37.9 5.9 (26.3 – 49.5)
Pennsylvania 413 50.5 4.0 (42.7 – 58.3) 431 48.7 3.8 (41.3 – 56.1)
Rhode Island 189 61.5 5.7 (50.3 – 72.7) 211 57.9 5.5 (47.1 – 68.7)
Texas 465 54.2 4.3 (45.8 – 62.6) 525 48.1 3.9 (40.5 – 55.7)
Utah 507 47.1 2.9 (41.4 – 52.8) 544 45.0 2.8 (39.5 – 50.5)
Vermont 240 62.8 3.7 (55.5 – 70.1) 254 59.6 3.8 (52.2 – 67.0)
Washington 374 60.7 4.3 (52.3 – 69.1) 389 51.6 5.1 (41.6 – 61.6)
West Virginia 237 54.5 4.2 (46.3 – 62.7) 236 56.4 4.2 (48.2 – 64.6)
Wisconsin 246 51.0 5.2 (40.8 – 61.2) 254 54.1 5.1 (44.1 – 64.1)
Puerto Rico 352 30.3 3.3 (23.8 – 36.8) 390 31.0 3.2 (24.7 – 37.3)
32 state total 8,766 51.1 1.3 (48.6 – 53.6) 9,322 49.5 1.3 (47.0 – 52.0)
Median   51.8       50.7    
Range   30.3-62.8       31.0-63.2    

1 Aged ≥ 18 years

2 “Yes” response to “Do you still have asthma?”

3 Reported any of the following during the past year: asthma medication use, asthma symptoms, or MD visits for asthma

± Landline and cell phone combined sample size excludes “DK/Refused”

§ Standard error

Confidence interval

TOP